Why the study?
With expanding pharmacotherapeutic options in neurology, cardiovascular adverse effects and drug-drug interactions are common, potentially life-threatening complications that can be prevented by proper drug selection.
What are the cardiovascular adverse effects and drug interactions associated with neurological and psychiatric drugs?
What are the cardiovascular adverse effects and drug interactions associated with neurological and psychiatric drugs?
Neurological and psychiatric medications carry significant risks of cardiovascular adverse effects and drug interactions, necessitating careful prescribing and interdisciplinary collaboration between neurologists, psychiatrists, cardiologists, and clinical pharmacists.
Answers are grounded in this paper and cite their sources.
Supports vigilant CV monitoring with neuro-psych drugs; leaves optimal collaboration protocols open for prospective study.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Boček et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: